Yui K, Goto K, Ikemoto S, Ishiguro T
Medical Care Section, Urawa Juvenile Classification Home, Ministry of Justice, Japan.
Ann N Y Acad Sci. 1996 Oct 31;801:415-29. doi: 10.1111/j.1749-6632.1996.tb17464.x.
The process that triggered spontaneous recurrence of methamphetamine (MAP)-induced paranoid-hallucinatory psychosis, a phenomenon known as flashbacks, was studied in 41 subjects with flashbacks, along with 84 subjects with a history of previous MAP psychosis but no flashbacks. Plasma levels of norepinephrine (NE), dopamine, and 5-hydroxytryptamine, and their respective metabolites were assayed in 28 of the 41 flashbackers, 16 of the 84 non-flashbackers, 9 subjects with persistent MAP psychosis, and 28 healthy controls comprised of 20 MAP users and 8 non-users. None of the 28 controls had become psychotic. The 41 flashbackers had experienced significantly greater frequencies of threatening events and frightening paranoid-hallucinatory states during previous MAP use than the 84 non-flashbackers. The dominant factor that triggered flashbacks was a mild fear of other persons. The 41 flashbackers may have encoded threatening experiences as frightening images. Repeated MAP use with threatening experiences may induce sensitization to frightening images. Plasma NE levels during flashbacks were significantly higher than the levels during periods of normalcy, and the NE levels in the 20 user and 8 non-user controls. The 9 subjects with persistent MAP psychosis had significant higher levels of NE than the user and non-user controls. The 16 non-flashbackers had significantly higher MHPG levels than the user controls. The findings suggest that MAP use may induce changes at pharmacological levels in the process underlying sensitization to frightening images. We suggested that when the flashbackers experienced a mild fear of other persons, MAP-induced sensitization to frightening images may have been actualized. Thus, the flashbacks may have been caused through increased noradrenergic hyperactivity.
在41名有闪回现象的受试者以及84名有甲基苯丙胺(MAP)所致偏执-幻觉性精神病病史但无闪回现象的受试者中,研究了引发MAP所致偏执-幻觉性精神病自发复发(即闪回现象)的过程。对41名有闪回现象的受试者中的28名、84名无闪回现象的受试者中的16名、9名患有持续性MAP精神病的受试者以及28名健康对照者(包括20名MAP使用者和8名非使用者)的血浆去甲肾上腺素(NE)、多巴胺和5-羟色胺水平及其各自的代谢产物进行了检测。28名对照者均未出现精神病症状。41名有闪回现象的受试者在既往使用MAP期间经历威胁事件和恐惧的偏执-幻觉状态的频率明显高于84名无闪回现象的受试者。引发闪回现象的主要因素是对他人的轻微恐惧。41名有闪回现象的受试者可能已将威胁经历编码为恐惧图像。反复使用MAP并伴有威胁经历可能会导致对恐惧图像的敏感化。闪回期间的血浆NE水平明显高于正常时期以及20名使用者和8名非使用者对照者的水平。9名患有持续性MAP精神病的受试者的NE水平明显高于使用者和非使用者对照者。16名无闪回现象的受试者的3-甲氧基-4-羟基苯乙二醇(MHPG)水平明显高于使用者对照者。研究结果表明,使用MAP可能会在对恐惧图像敏感化的潜在过程中在药理学水平上引起变化。我们认为,当有闪回现象的受试者对他人产生轻微恐惧时,MAP诱导的对恐惧图像的敏感化可能会被激活。因此,闪回现象可能是由去甲肾上腺素能活动增强引起的。